Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 502010780

Enzo Life Sciences BML-282 (5mg)
SDP

Catalog No. 502010780
Encompass_Preferred

Novel inhibitor of ubiquitin C-terminal hydrolase L1 (IC50 = 0.81 µM). It displays 21-fold greater selectivity over UCH-L3 (IC50 = 17 µM). Alternative name: N-(3,4-Dichlorobenzyl)-5-bromoisatin O-acetyloxime. Purity: ≥98% (TLC). Solubility: Soluble in DMSO (5mg/ml with warming) or dimethyl formamide (10mg/ml with warming). Long Term Storage: -20°C.

Catalog No. 50-201-0780 Supplier Enzo Life Sciences Supplier No. BMLEI4000005
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Novel inhibitor of ubiquitin C-terminal hydrolase L1 (IC50 = 0.81 µM). It displays 21-fold greater selectivity over UCH-L3 (IC50 = 17 µM). Alternative name: N-(3,4-Dichlorobenzyl)-5-bromoisatin O-acetyloxime. Purity: ≥98% (TLC). Solubility: Soluble in DMSO (5mg/ml with warming) or dimethyl formamide (10mg/ml with warming). Long Term Storage: -20°C.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.